C07K 14/5428
Il-10
Official title: {il-10}
C07K14/5428 (Il-10) appears on 230 US grants and 422 published applications in this corpus.
Search patents in C07K- Granted patents
- 230
- Published applications
- 422
- Assignees
- 226
- Inventors
- 769
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 0 |
| 2002 | 3 | 4 |
| 2003 | 4 | 10 |
| 2004 | 2 | 10 |
| 2005 | 4 | 12 |
| 2006 | 3 | 6 |
| 2007 | 10 | 6 |
| 2008 | 8 | 6 |
| 2009 | 3 | 5 |
| 2010 | 7 | 7 |
| 2011 | 5 | 6 |
| 2012 | 5 | 5 |
| 2013 | 3 | 8 |
| 2014 | 5 | 7 |
| 2015 | 2 | 5 |
| 2016 | 6 | 11 |
| 2017 | 2 | 15 |
| 2018 | 9 | 26 |
| 2019 | 8 | 22 |
| 2020 | 17 | 27 |
| 2021 | 18 | 34 |
| 2022 | 18 | 40 |
| 2023 | 14 | 33 |
| 2024 | 23 | 58 |
| 2025 | 9 | 30 |
| 2026 | 14 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- IL-10 muteins6 Oct 2026US 12,753,217 B2Universite De Lille
- Heterodimeric human IgG1 polypeptides with isoelectric point modifications23 Jun 2026US 12,662,553 B2Xencor, Inc.
- Immunocytokines for treatment of autoimmune and inflammatory conditions9 Jun 2026US 12,649,782 B2Horizon Therapeutics Ireland DAC
- Composition for treating pain26 May 2026US 12,636,346 B2Kolon Life Science, Inc.
- IL-10 muteins and fusion proteins thereof19 May 2026US 12,630,598 B2Amgen Inc.
- Method for producing group 2 innate lymphoid cells24 Sep 2026US 2026/0286297 A1Astellas Pharma Inc.
- Il-10 muteins and fusion proteins thereof17 Sep 2026US 2026/0274913 A1Amgen Inc.
- Engineered t cells3 Sep 2026US 2026/0258104 A1Intellia Therapeutics, Inc.
- Stem cells for transplantation and manufactauring method therefor20 Aug 2026US 2026/0240952 A1National Center of Neurology and Psychiatry
- Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins-4, -10, or a fusion protein thereof6 Aug 2026US 2026/0226123 A1Deka Biosciences, Inc.
Most cited
By later US patents
- Derivatives of growth hormone and related proteins160US 6,608,183 B1Bolder Biotechnology, Inc. · 2003
- Substantially pure histidine-linked protein polymer conjugates154US 5,985,263 AEnzon, Inc. · 1999
- Methods for determining genetic predisposition to autoimmune diseases by genotyping apoptotic genes102US 6,162,604 A2000
- Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)79US 5,231,012 ASchering Corporation · 1993
- Cysteine variants of granulocyte-macrophage colony-stimulating factor45US 7,148,333 B2Bolder Biotechnology, Inc. · 2006